The Daily Prophet
May 22, 2026 — Evening Edition

Dr. Vu Huynh, PharmD, PhD

Pharmaceutical PhD · IT Background
Zorvexus Labs
Exclusive

The bridge of the team the founder who first introduced the AI engineer to the medical founders, sparking the conversations that became Zorvexus a year later. Some companies begin with a pitch deck; this one began with a introduction over coffee.

Apharmaceutical research scientist with a parallel life in information technology, he moves between bench logic and server logs without changing temperament. Colleagues say he is the person who asks the question everyone avoided.

He holds both a PharmD and a PhD, credentials that let him speak fluently to regulators, formulary committees, and developers building models on clinical data. He makes interdisciplinary work look inevitable rather than heroic.

Long before the company had a name, he connected medicine and engineering in hallway conversations that became prototypes, then pilots, then the founding table. He is proof that translation is a discipline of its own.

Contact

As a founder, he champions adaptive AI for healthcare and education while guarding the nuance of drug discovery and patient safety. He will not trade precision for spectacle.

Among four founders, he is the connector the reason the lab feels like a single conversation instead of a collection of experts. When meetings drift, he restates the shared goal in one sentence.

Heritage rooted in Vietnam, career now centered in Oklahoma: he chose a place where the team could build slowly and seriously. His perspective keeps product roadmaps honest about chemistry, compliance, and culture.

He argued early that pharmaceutical research, information technology, and clinical medicine belonged in one agenda not three vendors. Zorvexus's architecture still reflects that argument in its seams.

Readers seeking the moral of his story should remember: breakthrough companies often need a bridge builder more than another brilliant soloist. Dr. Huynh chose to be that bridge, and the company crossed it together.